Adial Pharmaceuticals, Inc.ADILNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank80
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.46
↑ 94% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-7.76
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.46 | +67.6% |
| 2024 | -1.42 | -275.9% |
| 2023 | -0.38 | +17.6% |
| 2022 | -0.46 | +82.2% |
| 2021 | -2.58 | -32.5% |
| 2020 | -1.95 | +29.4% |
| 2019 | -2.76 | -31.9% |
| 2018 | -2.10 | +89.2% |
| 2017 | -19.46 | +57.7% |
| 2016 | -46.05 | - |